Differential changes in induced seizures after hippocampal treatment of rats with an antisense oligodeoxynucleotide to the GABA(A) receptor γ2 subunit

European Journal of Pharmacology

Volumn 340, Issue 2-3, 1997, Pages 153-160

  Karle, Jesper ^a,c   Laudrup, Peter ^b   Sams Dodd, Frank ^b   Mikkelsen, Jens D ^b   Nielsen, Mogens ^a  

^a Sct Hans Hospital   (Denmark)

^b H LUNDBECK A S   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

Animal behavior; Antisense oligodeoxynucleotide; Benzodiazepine receptor; Electroshock; GABA(A) receptor; Pentylenetetrazol; Seizure model; Social interaction

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; GABAERGIC TRANSMISSION; LOCOMOTION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SEIZURE; SOCIAL INTERACTION;

ANIMALS; AVOIDANCE LEARNING; CONVULSANTS; ELECTROSHOCK; HANDLING (PSYCHOLOGY); HIPPOCAMPUS; INTERPERSONAL RELATIONS; MALE; MOTOR ACTIVITY; OLIGONUCLEOTIDES, ANTISENSE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; RECEPTORS, GABA-A; SEIZURES;

EID: 0031565121     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01423-4     Document Type: Article

References (41)

1. Arnt J. Differential effects of classical and newer antipsychotics on the hypermobility induced by two dose levels of D-amphetamine. Eur. J. Pharmacol. 283:1995;55-62.
2. Bekenstein J.W., Lothman E.W. Dormancy of inhibitory interneurons in a model of temporal lobe epilepsy. Science. 259:1993;97-100.
3. Deyn P.P.D., Marescau B., Macdonald R.L. Epilepsy and the GABA-hypothesis, a brief review and some examples. Acta Neurol. Belg. 90:1990;65-81.
4. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods. 2:1980;219-238.
5. French E.D., Aldinio C., Schwarcz R. Intrahippocampal kainic acid, seizures and local neuronal degeneration: Relationships assessed in unanesthetized rats. Neuroscience. 7:1982;2525-2536.
6. Frey, H.-H., 1985. Primidone. In: Frey, H.-H., Janz, D. (Eds.), Antiepileptic Drugs. Handbook of Experimental Pharmacology. Springer, Berlin, vol. 74, pp. 449-477.
7. A receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359:1995;154-194.
8. A receptor subunit expression as a consequence of epileptiform activity in vitro. Neuroscience. 67:1995;849-865.
9. Hablitz J.J. Picrotoxin-induced epileptiform activity in hippocampus: Role of endogenous versus synaptic factors. J. Neurophysiol. 51:1984;1011-1027.
10. Heilig, M., Schlingensiepen, K.-H., 1996. Antisense oligodeoxynucleotides as novel neuropharmacological tools for selective expression blockade in the brain. In: Genetic Manipulation of the Nervous System. Academic Press, London, pp. 249-268.
11. Johansen F.F., O'Hare M.M.T. Loss of somatal neuropeptide Y immunoreactivity in the rat hippocampus following transient cerebral ischemia. J. Neurosurg. Anesthesiol. 1:1989;339-345.
12. Jones, G.L., Wimbish, G.H., 1985. Hydantoins. In: Frey, H.-H., Janz, D. (Eds.), Antiepileptic Drugs. Handbook of Experimental Pharmacology. Springer, Berlin, vol. 74, pp. 351-419.
13. A receptor γ2 subunit subtype. Eur. J. Pharmacol. Mol. Pharmacol. 291:1995;439-441.
14. A receptor γ2 subunit induces loss of neurones in rat hippocampus. Neurosci. Lett. 202:1995;97-100.
15. A receptors. Neurochem. Int. 31:1997;437-446.
16. A receptor γ2 subunit. Brain Res. 765:1997;21-29.
17. Kimball A.W., Burnett W.T., Doherty D.G. Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice. Radiat. Res. 7:1957;1-12.
18. Löscher, W., 1985. GABAmimetics in animal models of seizure states. In: Bartholini, G. et al. (Eds.), L. E. R. S. Raven Press, New York, vol. 3, pp. 109-119.
19. Löscher W., Fassbender C.P., Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res. 8:1991;79-94.
20. Löscher W., Hönack D., Fassbender C.P., Nolting B. The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 8:1991;171-189.
21. A receptor channels. Annu. Rev. Neurosci. 17:1994;569-602.
22. Meldrum, B.S., 1979. Convulsant drugs, anticonvulsants and GABA-mediated neuronal inhibition. In: Krogsgaard-Larsen, P., Scheel-Krüger, J., Kofoed, H. (Eds.), GABA-Neurotransmitters. Munksgaard, Copenhagen, pp. 390-405.
23. Meldrum B.S. GABAergic mechanisms in the pathogenesis and treatment of epilepsy. Br. J. Clin. Pharmacol. 27:1989;3S-11S.
24. Miller J.W., McKeon A.C., Ferrendelli J.A. Functional anatomy of pentylenetetrazol and electroshock seizures in the rat brainstem. Ann. Neurol. 22:1987;615-621.
25. Mirski M.A., McKeon A.C., Ferrendelli J.A. Anterior thalamus and substantia nigra: Two distinct structures mediating experimental generalized seizures. Brain Res. 397:1986;380-388.
26. Palmer G.C., Harris E.W., Ray R., Stagnitto M.L., Schmiesing R.J. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro. Arch. Int. Pharmacodyn. 317:1992;16-34.
27. Pisa M., Sanberg P.R., Corcoran M.E., Fibiger H.C. Spontaneously recurrent seizures after intracerebral injections of kainic acid in rat: A possible model of human temporal lobe epilepsy. Brain Res. 200:1980;481-487.
28. A receptor subunit for benzodiazepine pharmacology. Nature. 338:1989;582-585.
29. Sams-Dodd F. Automation of the social interaction test by a video-tracking system: Behavioural effects of repeated phencyclidine treatment. J. Neurosci. Methods. 59:1995;157-167.
30. Sams-Dodd F. Phencyclidine-induced stereotyped behaviour and social isolation in rats: A possible animal model of schizophrenia. Behav. Pharmacol. 7:1996;3-23.
31. Schmutz, M., 1985. Carbamazepine. In: Frey, H.-H., Janz, D. (Eds.), Antiepileptic drugs. Handbook of Experimental Pharmacology. Springer, Berlin, vol. 74, pp. 479-506.
32. Schwarcz R., Zaczek R., Coyle J.T. Microinjection of kainic acid into the rat hippocampus. Eur. J. Pharmacol. 50:1978;209-220.
33. A receptor subunits exist in distinct neuronal subpopulations. Neuron. 3:1989;327-337.
34. A receptor subtypes. Pharmacol. Rev. 47:1995;181-234.
35. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science. 235:1987;73-76.
36. Sloviter R.S. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: The Dormant Basket Cell hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus. 1:1991;41-66.
37. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
38. Thompson S.M. Consequences of epileptic activity in vitro. Brain Pathol. 3:1993;413-419.
39. Wahlestedt C. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15:1994;42-46.
40. Weng X., Rosenberg H.C. Infusion of bicuculline methiodide into the tectum: Model specificity of pro- and anticonvulsant actions. Epilepsy Res. 12:1992;1-8.
41. A receptor γ2 subunit increases convulsive threshold for β-CCM, a benzodiazepine 'inverse agonist', in rats. Eur. J. Pharmacol. 306:1996;61-66.